NCT00757497

Brief Summary

This study will test whether transcranial direct current stimulation (TDCS) can be used safely in children with schizophrenia and if it can improve memory and attention span or auditory hallucinations in these children, at least temporarily. TDCS has temporarily improved memory and attention span in healthy adults and a similar method called TMS has relieved auditory hallucinations in adults with schizophrenia. For the TDCS procedure, the child sits in a chair and two soft sponge electrodes are placed on the child s forehead and held in place with a soft wrapping. One sponge electrode is placed on an arm. The electrodes are attached to a stimulator with a wire. Children with schizophrenia who meet the following criteria may be eligible for this study:

  • Are 10 yrs or older age.
  • Are participating in NIH protocol 03-M-0035.
  • Are on a stable medication regimen for at least 6 months.
  • Have problems with memory and attention span or have auditory hallucinations. Participants are randomly assigned to receive either real or sham TDCS on an inpatient or outpatient basis in 20-minute sessions daily, except weekends, for 10 days. For real TDCS, patients receive stimulation to the front of the brain. For sham stimulation, the children have electrodes placed on the forehead, but no actual stimulation is delivered. In addition to TDCS, patients have the following procedures:
  • Checks of blood pressure, pulse and breathing rate before, during and right after each stimulation and again 8 hours later.
  • Electrocardiogram (EKG) and electroencephalogram (EEG) before starting stimulation and after completing the 10 days of TDCS.
  • Interviews and examinations to check for side effects of TDCS.
  • Pen-and-paper or computer tests of learning, attention and memory.
  • At the end of the 10 sessions, children who were in the sham TDCS group are offered the same number of sessions of active TDCS.
  • Follow-up telephone call 1 month after the end of stimulation to see how the child is doing.
  • 1- to 2-day outpatient visit 6 months after the stimulation. This visit includes interviews with the parent and the child, rating of the child s psychiatric symptoms, and pen-and-paper or computer tests of thinking, attention and memory.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Sep 2008

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2008

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

September 20, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 23, 2008

Completed
6.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 18, 2015

Completed
Last Updated

December 12, 2019

Status Verified

August 18, 2015

First QC Date

September 20, 2008

Last Update Submit

December 11, 2019

Conditions

Keywords

Treatment StudyPsychosisElectrical StimulationRefractoryNovelChildhood Onset Psychotic DisordersSchizophrenia

Outcome Measures

Primary Outcomes (1)

  • TDCS treatment is safe in childhood onset schizophrenia

Secondary Outcomes (1)

  • Improvement in cognition and psychosis

Interventions

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • COS patients (age 10 and above) recruited and followed under the current protocol 03-M-0035, where subjects have been stable (in the judgment of the investigator) on their medications for 2 months with or without PRN medications but continue to experience either:
  • Cognitive difficulties as evidenced by information from parents and teachers, clinical interview, and performance (below average based on published norms for each test) on neurocognitive tests (WMS-III Spatial Span (nonverbal) and WMS-III Letter-Number Sequencing (verbal) attention/vigilance (CPT-IP), and verbal learning (HVLT-R), all sub tests of the NIMH MATRICS battery).
  • Significant auditory hallucinations as measured by SAPS (scores above 2) or BPRS (scores above 3).

You may not qualify if:

  • Broken or abnormal skin in the area of the electrodes.
  • Presence of metal in the cranial cavity.
  • Holes in the skull from trauma or surgery.
  • Positive pregnancy test.
  • Presence of other psychiatric illness (e.g. severe anxiety, OCD etc) unless the patient has been on stable medication for the prior 2 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (4)

  • Asarnow JR, Ben-Meir S. Children with schizophrenia spectrum and depressive disorders: a comparative study of premorbid adjustment, onset pattern and severity of impairment. J Child Psychol Psychiatry. 1988 Jul;29(4):477-88. doi: 10.1111/j.1469-7610.1988.tb00738.x.

    PMID: 3215919BACKGROUND
  • Watkins JM, Asarnow RF, Tanguay PE. Symptom development in childhood onset schizophrenia. J Child Psychol Psychiatry. 1988 Nov;29(6):865-78. doi: 10.1111/j.1469-7610.1988.tb00759.x.

    PMID: 3235494BACKGROUND
  • Russell AT, Bott L, Sammons C. The phenomenology of schizophrenia occurring in childhood. J Am Acad Child Adolesc Psychiatry. 1989 May;28(3):399-407. doi: 10.1097/00004583-198905000-00017.

    PMID: 2738007BACKGROUND
  • Berman RA, Gotts SJ, McAdams HM, Greenstein D, Lalonde F, Clasen L, Watsky RE, Shora L, Ordonez AE, Raznahan A, Martin A, Gogtay N, Rapoport J. Disrupted sensorimotor and social-cognitive networks underlie symptoms in childhood-onset schizophrenia. Brain. 2016 Jan;139(Pt 1):276-91. doi: 10.1093/brain/awv306. Epub 2015 Oct 22.

MeSH Terms

Conditions

SchizophreniaPsychotic DisordersMental Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders

Study Officials

  • Nitin Gogtay, M.D.

    National Institute of Mental Health (NIMH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

September 20, 2008

First Posted

September 23, 2008

Study Start

September 17, 2008

Study Completion

August 18, 2015

Last Updated

December 12, 2019

Record last verified: 2015-08-18

Locations